NICE consults on expensive blood cancer treatment
NICE has invited comments and further evidence on a new treatment for aggressive subtypes of non-Hodgkin lymphoma called diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma that could lead to it being made available for use on the NHS.
The treatment, CAR-T could cure some patients but is very expensive. More....
